STU · Healthcare

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ)

Drug Manufacturers - Specialty & Generic

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) is listed on STU in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 2TZ

P/E ratio
18.00

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — FAQ

What is 2TZ's P/E ratio?

The price-to-earnings (P/E) ratio for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) is 18.00 (data as of 2026-05-24).

Does Tianjin Zhong Xin Pharmaceutical Group Corporation Limited pay a dividend?

Dividend yield is not available in the current snapshot for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ). Check the MyAverix Finance app for the latest dividend data.

What sector is Tianjin Zhong Xin Pharmaceutical Group Corporation Limited in?

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 2TZ listed on?

2TZ is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play